Qlucore AB engages in the provision on information technology systems and solutions. The company is headquartered in Lund, Skane and currently employs 20 full-time employees. The company went IPO on 2021-11-05. The Company’s scope of activity revolves around developing Artificial-Intelligence-based (AI-based) software dedicated to the healthcare sector. The software’s aim is to establish a platform improving cancer care in terms of treatment strategies, and more, as well as other therapy areas. What is more, the Firm develops software which is committed to data analysis in relation to medical research. The Company’s software relies on AI-based machine learning and functions by transforming data sets into explanatory visualizations. Additionally, the Firm runs three software products: Qlucore Omics Explorer, Qlucore Diagnostics, as well as Qlucore Insights.
Follow-Up Questions
Qlucore publ AB のCEOは誰ですか？
Mr. Carl-Johan Ivarsson は Qlucore publ AB の Chief Executive Officer で、2007 から在籍しています。
QLUCF の株価パフォーマンスは？
QLUCF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Qlucore publ AB の主な事業テーマや業界は？
Qlucore publ AB は Health Care 業界、セクターは Health Care に属しています。
